Nabi (NABI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Nabi (NABI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Spuria who wrote (89)	3/17/1997 12:33:00 PM
From: The BayWatcher	of 354

Today DLJ issued another newsletter on NABI. They said that the analyst meeting went very well. Gury told analysts that NABI's profit margins are growing and showcased NABI's R&D facilities. The DLJ analyst said that the presentation showed NABI was a very undervalued top-tier biotech company. Gury also said NABI expects to file for HBIG-IM (intra muscular??) this Spring although I'm not sure how this is diferent from HBIG-IV-- please advise. The DLJ analyst came up with several calculations multiplying actual and expected profits in 1996-98 to show that NABI should have a value of at least 16 and possibly up to 24. DLJ reiterated a strong buy with a 12 month target of 21. P.S. NABI may be held back by Biogen trading today, which I heard was down 10% despite gaining European approval on one os its products. NABI should move up soon. Xy & Tom: I finally bought 350 shares of COMS at 32 today via USRX at 56 (200shares). I had hoped to wait for 30-31 but didn't want to risk a bounce up from the 12:30 p.m. cable-related announcement by COMS. Good luck to all of us.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next